Shamburg News · 8-K filed Nov 12, 2026, 4:10 PM EST

Sanara MedTech Reports Third Quarter 2026 Results and Lowers Full-Year Net Revenue Guidance

SMTI · Sanara MedTech Inc.

  • Earnings
  • Materiality: high

Sanara MedTech Inc. reported net revenue of $28.4 million for the third quarter ended September 30, 2026, up 8% from $26.3 million a year earlier, and a loss from continuing operations of $1.3 million, or $0.15 per diluted share. Adjusted EBITDA was $5.6 million, and results included approximately $3.0 million of legal and advisory costs tied to the pending merger with MiMedx Group. The company updated its full-year 2026 net revenue guidance to $110 million to $115 million, down from the previously provided $116 million to $121 million.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 2.02, 9.01, accession 0001493152-26-051394.

Written from the filing by Shamburg Markets. Figures are as reported by the company.